• LAST PRICE
    2.0050
  • TODAY'S CHANGE (%)
    Trending Up0.0750 (3.8860%)
  • Bid / Lots
    2.0000/ 2
  • Ask / Lots
    2.0100/ 1
  • Open / Previous Close
    2.0000 / 1.9300
  • Day Range
    Low 1.9600
    High 2.0800
  • 52 Week Range
    Low 0.9550
    High 3.8700
  • Volume
    54,518
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 1.93
TimeVolumeBDSX
09:32 ET31032
09:33 ET2091.9632
09:35 ET5001.96
09:39 ET200002
09:44 ET103002.005
09:50 ET5002.05
09:51 ET12002.0413
10:02 ET112372
10:04 ET7002.07
10:13 ET15502.015
10:20 ET5002.0189
10:22 ET13102.005
10:29 ET5002.005
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBDSX
Biodesix Inc
138.4M
-1.2x
---
United StatesSTRM
Streamline Health Solutions Inc
128.6M
-11.7x
---
United StatesTALK
Talkspace Inc
130.5M
-1.5x
---
United StatesBGLC
BioNexus Gene Lab Corp
173.7M
-1,562.5x
---
United StatesMYNZ
Mainz Biomed NV
99.9M
-4.0x
---
United StatesCO
Global Cord Blood Corp
397.5M
4.9x
+20.97%
As of 2023-02-06

Company Information

Biodesix, Inc. is a United States-based company engaged in developing and commercializing blood-based diagnostic tests for oncology. The Company’s product Biodesix Lung Reflex integrates genomic and proteomic blood-based results to reveal both sides of lung cancer. Its GeneStrat test offers blood-based mutation results within 72 hours for patients with non-small cell lung cancer (NSCLC). Its VeriStrat testing provides blood-based predictive and prognostic proteomic information with (NSCLC) who test negative for estimated glomerular filtration rate (EGFR) mutations (EGFR wild-type) or whose EGFR mutation status is unknown.

Contact Information

Headquarters
Suite 100, 2970 Wilderness PlaceBOULDER, CO, United States 80301
Phone
303-417-0500
Fax
303-417-9700

Executives

Independent Chairman of the Board
John Patience
President, Chief Executive Officer, Director
Scott Hutton
Chief Financial Officer, Treasurer, Secretary
Robin Cowie
Chief Accounting Officer
Ryan Siurek
Director
Lawrence Kennedy

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$138.4M
Revenue (TTM)
$35.8M
Shares Outstanding
71.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.73
Book Value
$0.64
P/E Ratio
-1.2x
Price/Sales (TTM)
3.9
Price/Cash Flow (TTM)
---
Operating Margin
-143.67%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.